Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ludc webb

Nuno Dias

Associate professor

ludc webb

Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.


  • Nuno Dias
  • Stefan Acosta
  • Tim Resch
  • Björn Sonesson
  • Alaa Alhadad
  • Martin Malina
  • Krassi Ivancev

Summary, in English

BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination with the coeliac trunk (n = 6), was the predominant target vessel. No patient died within 30 days. Median follow-up was 43 (i.q.r. 25-63) months and the estimated (s.e.) 3-year overall survival rate was 76(7) per cent. Two patients died from distal SMA occlusive disease and intestinal infarction after 6 and 18 months respectively. Previous stroke (P = 0.016), male sex (P = 0.057) and age (P = 0.066) were associated with mid-term mortality on univariable, but not multivariable analysis. Reintervention was needed in 14 patients, achieving a 3-year cumulative rate of freedom from recurrent symptoms of 88(5) per cent. CONCLUSION:: Endovascular treatment provided high early and mid-term survival rates in this series of patients with CMI, with low complication rates. Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.


  • Vascular Diseases - Clinical Research
  • Radiology Diagnostics, Malmö

Publishing year







British Journal of Surgery



Document type

Journal article


Oxford University Press


  • Surgery



Research group

  • Vascular Diseases - Clinical Research
  • Radiology Diagnostics, Malmö


  • ISSN: 1365-2168